Top Markets
Coin of the day
Mega Genomics Limited Mega Genomics Limited

Mega Genomics Limited

6667
Classifica tra le azioni #18332
Mega Genomics Limited, a genetic testing platform company, offers consumer... Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson’s disease risk assessment; full-scale cancer risk assessment packages; myocardial infarction and heart failure genetic testing, a service and ancillary service that assesses the genetic risk of developing myocardial infarction and heart failure; cardiovascular and cerebrovascular disease risk assessment packages; hereditary breast cancer/ovarian cancer genetic testing; Septin9 colorectal cancer screening test; RNF180/Septin9 gastric cancer screening test; cervical cancer genetic methylation testing, a cervical cancer test; telomere length genetic testing that assesses the cell age and aging rate of a person; and personal whole genome test plus, a service that assesses the risk of developing multiple types of diseases and provides interpretation for various individual traits and medication advice. It also offers whole exome sequencing package for adults, a service that assesses the risk of developing multiple high-risk diseases, hereditary cancers, recessive genetic diseases, and types of complex diseases, as well as multiple drugs, dietary nutrition items, and exercise and fitness items; folate metabolic capacity assessment testing kits to assess the risk of developing cardiovascular and cerebrovascular diseases; ApoE gene testing for testing Alzheimer’s disease; BRCA1/2 gene mutation testing kits; Alzheimer’s disease screening kits; colorectal cancer screening kits; gastric cancer screening kits; lung nodule auxiliary diagnostic kits; and cervical cancer screening kits to health checkup centers and hospitals. The company was founded in 2016 and is headquartered in Beijing, China.
Prezzo delle azioni
$0.90827623
Capitalizzazione di mercato
$203.73M
Variazione (1 giorno)
0.35%
Variazione (1 anno)
-1.60%
Paese
CN
Scambia Mega Genomics Limited (6667)

Categoria

Storico del prezzo dell'azione per Mega Genomics Limited (6667)
Prezzo di chiusura più alto: $0.91 il 2026-09-01

Prezzo di chiusura più basso: $2.28 il 2022-06-01
Storico del prezzo dell'azione di Mega Genomics Limited dal 2022 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -1.68%
2025 -10.10%
2024 -1.39%
2023 -40.42%
2022 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$402.90 -1.16%
US
$52.89 -2.50%
DE
$61.54 -4.62%
SA
$258.96 38.55%
US
$2.04 25.10%
MY